Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment

Clicks: 482
ID: 114701
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 40 articles by views in Cancer research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Acute lymphoblastic leukemias (ALL) positive for KMT2A/AFF1 (MLL/AF4) translocation, which constitute 60% of all infant ALL cases, have a poor prognosis even after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This poor prognosis is due to one of two factors, either r …
Reference Key
h2017canceramlexanox Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tamai H;Yamaguchi H;Miyake K;Takatori M;Kitano T;Yamanaka S;Yui S;Fukunaga K;Nakayama K;Inokuchi K;;
Journal Cancer research
Year 2017
DOI
DOI not found
URL
https://www.pubmed.gov/28646023/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't male Disease Models Animal DNA-Binding Proteins / metabolism* hiroki yamaguchi koiti inokuchi nuclear proteins / metabolism transgenic scid dna-binding proteins / genetics down-regulation pmid:28646023 doi:10.1158/0008-5472.can-16-2974 hayato tamai aminopyridines / pharmacology* anti-allergic agents / administration & dosage anti-allergic agents / pharmacology antineoplastic combined chemotherapy protocols / pharmacology* cell cycle proteins / genetics cell cycle proteins / metabolism* drug synergism inbred nod nuclear proteins / genetics precursor cell lymphoblastic leukemia-lymphoma / drug therapy* precursor cell lymphoblastic leukemia-lymphoma / metabolism precursor cell lymphoblastic leukemia-lymphoma / pathology s100 calcium binding protein a6 s100 proteins / genetics s100 proteins / metabolism* transcriptional elongation factors / genetics transcriptional elongation factors / metabolism* tumor necrosis factor-alpha / administration & dosage tumor necrosis factor-alpha / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.